Impact of Preoperative Symptom Duration on Patient-reported Outcomes After Minimally Invasive Transforaminal Interbody Fusion for Degenerative Spondylolisthesis.
Timothy J HartmanJames W NieFatima N AnwarAndrea M RocaAlexandra C LoyaSrinath S MedakkarKeith R MacGregorOmolabake O OyetayoEileen ZhengVincent P FedericoDustin H MasselArash J SayariGregory D LopezKern SinghPublished in: Clinical spine surgery (2024)
Regardless of the symptom duration before MIS-TLIF for DSpond, patients demonstrate significant improvement in physical function, pain, disability, and mental health. Patients with a GD of preoperative symptoms did not report inferior scores in any PROM domain. Patients with a GD of preoperative symptoms did not suffer inferior rates of clinically meaningful improvement after surgical intervention. These findings should be considered when counseling patients before surgical intervention for DSpond.
Keyphrases
- minimally invasive
- patient reported outcomes
- end stage renal disease
- mental health
- randomized controlled trial
- ejection fraction
- newly diagnosed
- chronic kidney disease
- patients undergoing
- multiple sclerosis
- peritoneal dialysis
- chronic pain
- patient reported
- physical activity
- depressive symptoms
- spinal cord injury
- spinal cord